Resources

/Resources
Resources 2021-04-28T14:16:20-04:00

RESOURCES

Browse our Resources

Use the below filters and search to find publications including Amicus Briefs, Testimony and Comments, IPO Law Journal Articles, and the IPO Federal Circuit Summaries™.

TITLE PUBLISHED CATEGORY
IPO Comments on Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights February 06, 2024 Testimony and Comments
IPO Comments Regarding FTC’s Petition for Rulemaking of PIRG and iFixit February 02, 2024 Testimony and Comments
IPO 2024 Special 301 Review Comments January 30, 2024 Testimony and Comments
IPO’s Notice of Intent to Testify and Hearing Statement re: 2024 Special 301 January 30, 2024 Testimony and Comments
IPO’s Comments to Department of Health and Human Services Re: Implications of Access and Benefit Sharing (ABS) Commitments/Regimes and Other Proposed Commitments in the WHO Pandemic Agreement January 29, 2024 Testimony and Comments
IPO Comments to USPTO on WIPO IGC Negotiations on Genetic Resources and Associated Traditional Knowledge January 22, 2024 Testimony and Comments
IPO Comments to the U.S. Copyright Office re: Artificial Intelligence and Copyright October 30, 2023 Testimony and Comments
IPO Comments Regarding Revision of India’s Manual of Designs Practice and Procedure October 12, 2023 Testimony and Comments
Comments to the USPTO on Changes to Duration of Trademark Attorney Recognition October 06, 2023 Testimony and Comments
IPO Comments to USTR Regarding 2023 Notorious Markets October 06, 2023 Testimony and Comments
IPO Comments to USPTO on Future Strategies for Anticounterfeiting and Piracy September 25, 2023 Testimony and Comments
IPO Comments Regarding India’s “Draft Patents (Amendment), Rules, 2023.” September 20, 2023 Testimony and Comments
IPO Comments to European Patent Office Regarding User Consultation on the Proposed Amendments to the Rules of Procedure of the Boards of Appeal August 31, 2023 Testimony and Comments
IPO Comments to USPTO Regarding Proposed Design Patent Practitioner Bar August 14, 2023 Testimony and Comments
IPO Comments to European Commission On EU Compulsory Licensing Proposal July 31, 2023 Testimony and Comments
IPO Comments to USPTO Regarding Motion To Amend Pilot Program and Rules of Practice To Allocate the Burdens of Persuasion on Motions To Amend in Trial Proceedings Before the PTAB July 24, 2023 Testimony and Comments
IPO Comments to USPTO Regarding Advance Notice of Proposed Rulemaking on PTAB Discretionary Institution Practices June 20, 2023 Testimony and Comments
IPO Comments Regarding USPTO Proposed Trademark Fee Schedule June 12, 2023 Testimony and Comments
IPO Comments to Patent Public Advisory Committee re: USPTO Proposed Patent Fee Adjustments May 25, 2023 Testimony and Comments
IPO Comments to USPTO Regarding Artificial Intelligence and Inventorship May 15, 2023 Testimony and Comments
IPO Comments to FTC Regarding Non-Compete Clause Rule, Matter No. P201200 April 17, 2023 Testimony and Comments
IPO Comments on the Updated EPO Guidelines for Examination March 31, 2023 Testimony and Comments
IPO Testimony to U.S. ITC Regarding  COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities March 29, 2023 Testimony and Comments
IPO Response to Questions Re: USTR 2023 Special 301 Review March 07, 2023 Testimony and Comments
IPO Comments to CNIPA on Draft Amendment to the Trademark Law February 27, 2023 Testimony and Comments
IPO’s Comments on the Draft 2022-2026 USPTO Strategic Plan February 16, 2023 Testimony and Comments
IPO Comments on Joint USPTO–FDA Collaboration Initiatives February 06, 2023 Testimony and Comments
IPO Comments Regarding USPTO Initiatives To Ensure the Robustness and Reliability of Patent Rights February 01, 2023 Testimony and Comments
IPO Comments Regarding Expanding Opportunities to Appear Before the Patent Trial and Appeal Board January 31, 2023 Testimony and Comments
IPO Comments Regarding Expanding Admission Criteria for Registration to Practice in Patent Cases Before the United States Patent and Trademark Office January 31, 2023 Testimony and Comments
IPO 2023 Special 301 Review Comments January 30, 2023 Testimony and Comments
IPO Comments to UKIPO Regarding Transformation Consultation January 05, 2023 Testimony and Comments
IPO Comments to CNIPA on Draft Revised Patent Examination Guidelines December 14, 2022 Testimony and Comments
IPO Comments in Response to USPTO Regarding Director Review October 19, 2022 Testimony and Comments
IPO Comments to USPTO Regarding Subject Matter Eligibility Guidance October 15, 2022 Testimony and Comments
IPO Comments to USTR Regarding Notorious Markets Review October 07, 2022 Testimony and Comments
IPO Comments Regarding Proposed Rulemaking Pertaining to Patent Term Adjustment October 04, 2022 Testimony and Comments
IPO and Other Associations Joint Statement of Support For Existing IP Framework to Facilitate Innovation and Partnerships October 04, 2022 Testimony and Comments
IPO Responses to EU Questionnaire Regarding Compulsory Licensing September 29, 2022 Testimony and Comments
IPO Letter to Senator Tillis re: Introduction of Patent Eligibility Restoration Act of 2022 August 03, 2022 Testimony and Comments
Load More